Characterization of the interactions of a polycationic, amphiphilic, terminally branched oligopeptide with lipid A and lipopolysaccharide from the deep rough mutant of Salmonella minnesota

Journal of Endotoxin Research

Volumn 3, Issue 5, 1996, Pages 369-379

  David, S A ^a,b,e   Awasthi, S K ^b   Wiese, A ^c   Ulmer, A J ^c   Lindner, B ^c   Brandenburg, K ^c   Seydel, U ^c   Rietschel, E Th ^c   Sonesson, A ^d   Balaram, P ^b  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b INDIAN INSTITUTE OF SCIENCE   (India)

^c RESEARCH CENTER BORSTEL   (Germany)

^d ASTRAZENECA R AND D   (Sweden)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; LIPID A; LIPOPOLYSACCHARIDE; OLIGOPEPTIDE; POLYMYXIN B; SYNTHETIC PEPTIDE;

ADULT; ARTICLE; HUMAN; HUMAN CELL; MUTANT; NEUTROPHIL; NORMAL HUMAN; SALMONELLA MINNESOTA;

SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR MINNESOTA;

EID: 10544252681     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/096805199600300501     Document Type: Article

References (64)

1. Hamill R.J., Maki D.G. Endotoxin shock in man caused by Gram-negative bacilli - etiology, clinical features, diagnosis, natural history and prevention. In: Proctor R.A. (ed.) Handbook of Endotoxin (Clinical Aspects of Endotoxic Shock). Amsterdam: Elsevier, 1984; 55-114.
2. Aldrige S. Meeting the challenge of sepsis. Trends Biotechnol 1995; 11: 373-375.
3. Sundaresan R., Sheagren J.N. Current understanding and treatment of sepsis. Complications Surg 1995; 14: 261-268.
4. Cross A.S., Opal S. Therapeutic intervention in sepsis with antibody to endotoxin: is there a future? J Endotoxin Res 1994; 1: 57-69.
5. Dentener MA, Von Asmuth E.J.U., Francot G.J.M., Marra M.N., Buurman W.A. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes: competition for binding to lipopolysaccharide. J Immunol 1993; 151: 4258-4265.
6. Elsbach P., Weiss J. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against Gram-negative bacteria and lipopolysaccharide. Immunobiology 1993; 187: 417-429.
7. Fisher Jr C.J., Marra M.N., Palardy J.E., Marchbanks C.R., Scott R.W., Opal S.M. Human neutrophil bactericidal/permeability-increasing protein reduces mortality rate from endotoxin challenge: a placebo-controlled study. Crit Care Med 1994; 22: 553-558.
8. Nelson D., Kuppermann N., Fleisher G.R. et al. Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats. Crit Care Med 1995; 23: 92-98.
9. Christ W.J., Asano O., Robidoux A.L.C. et al. E5531, a pure endotoxin antagonist of high potency. Science 1995; 268: 80-83.
10. Kirikae X, Schade F.U., Kirikae F., Qureshi N., Takayama K., Rietschel E.T. Diphosphoryl lipid A derived from the lipopolysaccharide (LPS) of Rhodobacter sphaeroides ATCC 17023 is a potent competitive LPS inhibitor in murine macrophage-like J774.1 cells. FEMS Immunol Med Microbiol 1994; 9: 237-244.
11. Loppnow H., Libby P., Freudenberg M., Krauss J.H., Weckesser J., Mayer H. Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS. Infect Immun 1990; 58: 3743-3750.
12. Novogrodsky A., Vanichkin A., Patya M., Gazit A., Osherov N., Levitzki A. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 1994; 264: 1319-1322.
13. Quezado Z.M.N., Banks S.M., Natanson C. New strategies for combating sepsis: the magic bullets missed the mark ... but the search continues. Trends Biotechnol 1995; 13: 56-63.
14. David S.A., Mathan V.I., Balaram P. Interaction of melittin with endotoxic lipid A. Biochim Biophys Acta 1992; 1123: 269-274.
15. David S.A., Balasubramanian K.A., Mathan V.I., Balaram P. Analysis of the binding of polymyxin B to endotoxic lipid A and core glycolipid using a fluorescent displacement probe. Biochim Biophys Acta 1992; 1165: 147-152.
16. David S.A., Balaram P., Mathan V.I. Interaction of basic amphiphilic polypeptide antimicrobials, gramicidin S, tyrocidin and efrapeptin, with endotoxic lipid A. Med Microbiol Lett 1993; 2: 42-47.
17. Bhattacharjya S., David S.A., Mathan V.I., Balaram P. Polymyxin B nonapeptide: conformations in water and in the lipopolysaccharide-bound state determined by two-dimensional NMR and molecular dynamics. Biopolymers 1996; In press.
18. David S.A., Bechtel B., Annaiah C., Mathan V.I., Balaram P. Interaction of cationic amphiphilic drugs with lipid A: implications for development of endotoxin antagonists. Biochim Biophys Acta 1994; 1212: 167-175.
19. David S.A., Mathan V.I., Balaram P. Interactions of linear dicationic molecules with lipid A: structural requisites for optimal binding affinity. J Endotoxin Res 1995; 2: 235-336.
20. David S.A. Analysis of the desirable structural properties in potential endotoxin antagonists. PhD Thesis, Christian Medical College Hospital, Vellore, India, 1995.
21. David S.A., Balaram P., Mathan V.I. Characterization of the interaction of lipid A and lipopolysaccharide with human serum albumin: implications for an endotoxin carrier function for albumin. J Endotoxin Res 1995; 2: 99-106.
22. Srimal S., Surolia N., Balasubramanian S., Surolia A. Titration calorimetric studies to elucidate the specificity of the interactions of polymyxin B with lipopolysaccharides and lipid A. Biochem J 1996; 315: 679-686.
23. Tobias P.S., Ulevitch R.J. Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation. Immunobiology 1993; 187: 227-232.
24. Schumann R.R. Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: a short review. Res Immunol 1992; 143: 11-15.
25. Schumann R.R., Lamping N., Kirschning C., Knopf H-P., Hoess A., Herrmann F. Lipopolysaccharide binding protein: its role and therapeutical potential in inflammation and sepsis. Biochem Soc Trans 1994; 22: 80-82.
26. 23) is a universal lipopolysaccharide-binding ligand. Infect Immun 1994; 62: 3564-3567.
27. Wilde C.G., Seilhamer J.J., McGrogan M. et al. Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS)-binding protein. LPS binding properties and effects on LPS-mediated cell activation. J Biol Chem 1994; 269: 17411-17416.
28. Evans T.J., Carpenter A., Moyes D., Martin R., Cohen J. Protective effects of a recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in an animal model of Gram-negative sepsis. J Infect Dis 1995; 171: 153-160.
29. Sheldon K., Liu D., Ferguson J., Gariepy J. Loligomers: design of de novo peptide-based intracellular vehicles. Proc Natl Acad Sci USA 1995; 92: 2056-2060.
30. Rao C., Tam J.P. Synthesis of peptide dendrimer. J Am Chem Soc 1994; 116: 6975-6976.
31. Chapman T.M., Hillyer G.L., Mahan E.J., Shaffer K.A. Hydramphiphiles: novel linear dendritic block copolymer surfactants. J Am Chem Soc 1994; 116: 11195-11196.
32. Munson P.J., Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980; 107: 220-239.
33. Eisenberg M., Gresalfi T., Riccio T., McLaughlin S. Adsorption of monovalent cations to bilayer membranes containing negative phospholipids. Biochemistry 1979; 18: 5213-5223.
34. Beschiaachvili G., Seelig J. Peptide binding to lipid bilayers. Nonclassical hydrophobic effect and membrane-induced pK shifts. Biochemistry 1992; 31: 10044-10053.
35. Beschiaachvili G., Seelig J. Peptide binding to lipid membranes. Spectroscopic studies on the insertion of a cyclic somatostatin analog into phospholipid bilayers. Biochim Biophys Acta 1991; 1061: 78-84.
36. Winiski A.P., McLaughlin A., McDaniel R.V., Eisenberg M., McLaughlin S. An experimental test of the discreteness-of-charge effect in positive and negative lipid bilayers. Biochemistry 1986; 25: 8206-8214.
37. Hong K., Baldwin P.A., Allen T.M., Papahadjopoulos D. Fluorometric detection of the bilayer-to-hexagonal phase transition in liposomes. Biochemistry 1988; 27: 3947-3955.
38. 2+-induced fusion of phosphatidylserine vesicles: effects of poly(ethylene glycol). Biochim Biophys Acta 1994; 1191: 375-383.
39. Seydel U., Brandenburg K. Supramolecular structure of lipopolysaccharide and free lipid A under physiological conditions as determined by synchrotron small-angle X-ray diffraction. Eur J Biochem 1989; 186: 325-332.
40. Brandenburg K., Koch M.H.J., Seydel U. Phase diagram of deep rough mutant lipopolysaccharide from Salmonella minnesota R595. J Struct Biol 1992; 108: 93-106.
41. Seydel U., Brandenburg K. Supramolecular structure of lipopolysaccharides and lipid A. In: Bacterial Endotoxic Lipopolysaccharides Vol. I: Molecular biochemistry and cellular biology. Boca Raton: CRC Press, 1993; 225-250.
42. Schindler P.R.G., Teuber M. Action of polymyxin B on bacterial membranes: morphological changes in the cytoplasm and in the outer membrane of Salmonella typhimurium and Escherichia coli B. Antimicrob Agents Chemother 1975; 8: 95-104.
43. Teuber M., Baader J. Action of polymyxin B on bacterial membranes. Binding capacities for polymyxin B of inner and outer membranes isolated from Salmonella typhimurium G30. Arch Microbiol 1976; 109: 51-58.
44. Vaara M., Vaara T. Polycations as outer membrane disorganizing agents. Antimicrob Agents Chemother 1983; 24: 114-122.
45. Vaara M. Agents that increase the permeability of the outer membrane. Microbiol Rev 1992; 56: 395-411.
46. Kagan B.L., Ganz X., Lehrer R.I. Defensins: a family of antimicrobial and cytotoxic peptides. Toxicology 1994; 87: 131-149.
47. Zhong L., Putnam R.J., Johnson Jr W.C., Rao A.G. Design and synthesis of amphipathic antimicrobial peptides. Int J Peptide Protein Res 1995; 45: 337-347.
48. Piers K.L., Brown M.H., Hancock R.E.W. Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification. Antimicrob Agents Chemother 1994; 38: 2311-2316.
49. Schröder G., Brandenburg K., Seydel U. Polymyxin B induces transient permeability fluctuations in asymmetric planar lipopolysaccharide/phospholipid bilayers. Biochemistry 1992; 31: 631-638.
50. Seydel U., Brandenburg K., Schröder G. Reconstitution of the lipid matrix of the outer membrane of Gram-negative bacteria as asymmetric planar bilayer. J Membr Biol 1989; 109: 95-103.
51. Schröder G., Brandenburg K., Brade L., Seydel U. Pore formation by complement in the outer membrane of Gram-negative bacteria studied with asymmetric planar lipopolysaccharide/phospholipid bilayers. J Membr Biol 1990; 118: 161-170.
52. + complex. Z Naturforsch 1992; 47c: 757-761.
53. Neulieb R.L., Neulieb M,K. The diverse actions of dimethylsulfoxide: an indicator of membrane transport activity. Cytobios 1990; 63: 139-165.
54. Anchordoguy T.J., Carpenter J.F., Crowe J.H., Crowe L.M. Temperature-dependent perturbation of phospholipid bilayers by dimethylsulfoxide. Biochim Biophys Acta 1992; 1104: 117-122.
55. Anchordoguy T.J., Carpenter J.F., Cecchini C.A., Crowe J.H., Crowe L.M. Effects of protein perturbants on phospholipid bilayers. Arch Biochem Biophys 1990; 283: 356-361.
56. Loppnow H., Flad H-D., Dürrbaum I. et al. Detection of interleukin 1 with human dermal fibroblasts. Immunobiology. 1989; 179: 283-291.
57. 1 nonapeptide with phosphatidic acid monolayer and bilayer membranes. Chem Phys Lipids 1988; 47: 155-163.
58. Kubesch P., Boggs J., Luciano L., Maass G., Tümmler B. Interaction of polymyxin B nonapeptide with anionic phospholipids. Biochemistry 1987; 26: 2139-2149.
59. Theretz A., Theissie J., Tocanne J.F. A study of the structure and dynamics of complexes between polymyxin B and phosphatidylglycerol in monolayers by fluorescence. Eur J Biochem 1984; 142: 113-119.
60. Sixl F., Galla H-J. Calorimetric investigation of polymyxin binding to phosphatidic acid bilayers. Biochim Biophys Acta 1982; 693: 466-478.
61. El Mashak E.M., Tocanne J.F. Polymyxin B phosphatidylglycerol interactions; a monolayer study. Biochim Biophys Acta 1980; 596: 165-179.
62. Hartmann W., Galla H. Binding of polylysine to charged bilayer membranes. Molecular organization of a lipid-peptide complex. Biochim Biophys Acta 1978; 509: 474-490.
63. Rustici A., Velucchi M., Faggioni R. et al. Molecular mapping and detoxification of the lipid A binding site by synthetic peptides. Science 1993; 259: 361-365.
64. Park N.G., Lee S., Oishi O. et al. Conformation of tachyplesin I from Tachypleus tridentatus when interacting with lipid matrices. Biochemistry 1992; 31: 12241-12247.